Cho Kwang Pain (004910) — Capital Reinvestment Ratio

Latest as of September 2025: 0.65x

Cho Kwang Pain (004910) has a Capital Reinvestment Ratio of 0.65x as of September 2025, meaning it reinvests 1% of its operating cash flow (₩3.56 Billion) in capital expenditures (₩2.30 Billion). See 004910 net asset quality score to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.65x
Capex / Operating Cash Flow

Operating Cash Flow

₩3.56 Billion
KRW

Capital Expenditures

₩2.30 Billion
KRW

Data as of

Sep 2025
Most recent filing

Cho Kwang Pain Capital Reinvestment Ratio (2012–2024)

This chart tracks Cho Kwang Pain's Capital Reinvestment Ratio across 10 annual periods. Check Cho Kwang Pain cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Cho Kwang Pain (2012–2024)

Year-by-year Capital Reinvestment Ratio for Cho Kwang Pain from 2012 to 2024. For live market cap and broader valuation context, see 004910 market cap overview.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2024 0.67x ₩19.75 Billion ₩13.30 Billion ▼ -22.7%
2023 0.87x ₩14.78 Billion ₩12.87 Billion ▲ +11.5%
2020 0.78x ₩14.33 Billion ₩11.19 Billion ▼ -41.4%
2019 1.33x ₩12.31 Billion ₩16.39 Billion ▼ -7.5%
2017 1.44x ₩13.43 Billion ₩19.32 Billion ▲ +330.8%
2016 0.33x ₩18.15 Billion ₩6.06 Billion ▲ +140.1%
2015 0.14x ₩21.20 Billion ₩2.95 Billion ▼ -82.2%
2014 0.78x ₩19.45 Billion ₩15.20 Billion ▲ +120.2%
2013 0.35x ₩9.85 Billion ₩3.50 Billion ▼ -44.0%
2012 0.63x ₩7.55 Billion ₩4.78 Billion
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow